Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Sell
70,725
-111,898
-61% -$1.99M 0.01% 361
2026
Q1
$3.48M Buy
182,623
+41,478
+29% +$802K 0.05% 238
2025
Q4
$2.31M Sell
141,145
-11,134
-7% -$196K 0.03% 295
2025
Q3
$2.86M Buy
152,279
+28,500
+23% +$511K 0.04% 264
2025
Q2
$2.5M Buy
123,779
+74,330
+150% +$1.28M 0.04% 260
2025
Q1
$680K Buy
49,449
+4,491
+10% +$61.8K 0.01% 332
2024
Q4
$533K Buy
44,958
+29,735
+195% +$468K 0.01% 341
2024
Q3
$273K Buy
+15,223
New +$278K ﹤0.01% 347

Other funds holding XP

LBP AM's XP Position: Q2 2026 in Review

LBP AM reduced its XP (XP) stake by 61% in Q2 2026, selling an estimated $1.99M and leaving 70,725 shares worth $1.15M. The position accounts for 0.01% of the portfolio, ranked #361.

LBP AM first reported a position in XP in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.48M in Q1 2026. 320 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • LBP AM held 70,725 shares of XP worth $1.15M as of Q2 2026.
  • LBP AM sold 111,898 XP shares in Q2 2026, an estimated $1.99M.
  • XP made up 0.01% of LBP AM's portfolio in Q2 2026, its #361 holding.
  • LBP AM first reported a position in XP in Q3 2024 and has held it in 8 quarters since.
  • LBP AM's XP position peaked at $3.48M in Q1 2026.
  • 320 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on LBP AM's 13F filing for Q2 2026, filed 24 Jul 2026.